Green Cures & Botanical Distribution Inc. Logo

Green Cures & Botanical Distribution Inc.

GRCU

(1.0)
Stock Price

0,00 USD

29.23% ROA

89.83% ROE

1.81x PER

Market Cap.

783.949,00 USD

42% DER

0% Yield

17.28% NPM

Green Cures & Botanical Distribution Inc. Stock Analysis

Green Cures & Botanical Distribution Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Green Cures & Botanical Distribution Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (-192%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

The stock's ROE indicates a negative return (-1491.38%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-634.56%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Green Cures & Botanical Distribution Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Green Cures & Botanical Distribution Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Sell
4 Stoch RSI Hold

Green Cures & Botanical Distribution Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Green Cures & Botanical Distribution Inc. Revenue
Year Revenue Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2015 20.199 100%
2016 6.800 -197.04%
2017 112.960 93.98%
2018 142.516 20.74%
2019 182.833 22.05%
2020 191.672 4.61%
2021 135.861 -41.08%
2022 102.083 -33.09%
2023 2.250.402 95.46%
2024 3.009.392 25.22%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Green Cures & Botanical Distribution Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Green Cures & Botanical Distribution Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 2.258.528 100%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Green Cures & Botanical Distribution Inc. EBITDA
Year EBITDA Growth
2005 -21.456
2006 -5.414.207 99.6%
2007 -7.493.341 27.75%
2008 -4.937.640 -51.76%
2015 -95.620 -5063.82%
2016 -2.766.450 96.54%
2017 72.840 3897.98%
2018 90.210 19.26%
2019 63.060 -43.05%
2020 21.910 -187.81%
2021 -509.140 104.3%
2022 -415.500 -22.54%
2023 483.270 185.98%
2024 1.074.920 55.04%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Green Cures & Botanical Distribution Inc. Gross Profit
Year Gross Profit Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2015 -10.456 100%
2016 2.380 539.33%
2017 87.495 97.28%
2018 119.349 26.69%
2019 153.747 22.37%
2020 143.385 -7.23%
2021 8.594 -1568.43%
2022 74.605 88.48%
2023 1.248.353 94.02%
2024 1.775.416 29.69%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Green Cures & Botanical Distribution Inc. Net Profit
Year Net Profit Growth
2005 -21.695
2006 -6.552.079 99.67%
2007 -12.525.168 47.69%
2008 -9.053.676 -38.34%
2015 -95.617 -9368.69%
2016 -2.779.546 96.56%
2017 51.608 5485.88%
2018 66.748 22.68%
2019 63.062 -5.85%
2020 10.118 -523.27%
2021 -520.752 101.94%
2022 -452.045 -15.2%
2023 408.826 210.57%
2024 992.584 58.81%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Green Cures & Botanical Distribution Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Green Cures & Botanical Distribution Inc. Free Cashflow
Year Free Cashflow Growth
2005 -20.852
2006 -5.520.911 99.62%
2007 -6.311.931 12.53%
2008 -1.304.513 -383.85%
2015 -56.959 -2190.27%
2016 2.354 2519.67%
2017 -154.000 101.53%
2018 -14.845 -937.39%
2019 -282.208 94.74%
2020 -521.251 45.86%
2021 -216.042 -141.27%
2022 -117.609 -83.7%
2023 32.442 462.52%
2024 316.515 89.75%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Green Cures & Botanical Distribution Inc. Operating Cashflow
Year Operating Cashflow Growth
2005 -20.852
2006 -5.107.281 99.59%
2007 -6.163.912 17.14%
2008 -1.304.513 -372.51%
2015 -56.959 -2190.27%
2016 2.354 2519.67%
2017 -154.000 101.53%
2018 -14.845 -937.39%
2019 -282.208 94.74%
2020 -4.252 -6537.06%
2021 -216.042 98.03%
2022 -117.609 -83.7%
2023 32.442 462.52%
2024 316.515 89.75%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Green Cures & Botanical Distribution Inc. Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 413.630 100%
2007 148.019 -179.44%
2008 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 516.999 100%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Green Cures & Botanical Distribution Inc. Equity
Year Equity Growth
2005 -8.614
2006 3.091.623 100.28%
2007 -1.411.946 318.96%
2008 -8.295.916 82.98%
2015 -13.444 -61607.2%
2016 -310.594 95.67%
2017 -321.267 3.32%
2018 -43.692 -635.3%
2019 -24.054 -81.64%
2020 57.250 142.02%
2021 4.768 -1100.71%
2022 -197.625 102.41%
2023 734.419 126.91%
2024 872.401 15.82%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Green Cures & Botanical Distribution Inc. Assets
Year Assets Growth
2005 229
2006 3.368.967 99.99%
2007 2.172.056 -55.1%
2008 1.584.893 -37.05%
2015 69.743 -2172.48%
2016 406 -17078.08%
2017 996 59.24%
2018 4.819 79.33%
2019 3.886 -24.01%
2020 527.005 99.26%
2021 627.288 15.99%
2022 608.068 -3.16%
2023 1.752.054 65.29%
2024 2.046.666 14.39%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Green Cures & Botanical Distribution Inc. Liabilities
Year Liabilities Growth
2005 8.843
2006 277.344 96.81%
2007 3.584.002 92.26%
2008 9.880.809 63.73%
2015 83.188 -11777.69%
2016 311.000 73.25%
2017 322.263 3.49%
2018 373.210 13.65%
2019 27.940 -1235.76%
2020 469.755 94.05%
2021 631.895 25.66%
2022 805.693 21.57%
2023 1.031.635 21.9%
2024 1.174.265 12.15%

Green Cures & Botanical Distribution Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
1.81x
Price To Sales Ratio
0.23x
POCF Ratio
13.12
PFCF Ratio
9.49
Price to Book Ratio
1.24
EV to Sales
0.23
EV Over EBITDA
1.17
EV to Operating CashFlow
9.55
EV to FreeCashFlow
9.55
Earnings Yield
0.55
FreeCashFlow Yield
0.11
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
0
Income Quality
0.14
ROE
0.9
Return On Assets
0.29
Return On Capital Employed
0.71
Net Income per EBT
1
EBT Per Ebit
0.97
Ebit per Revenue
0.18
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.49
Operating Profit Margin
0.18
Pretax Profit Margin
0.17
Net Profit Margin
0.17

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.5
Return on Tangible Assets
0.29
Days Sales Outstanding
80.9
Days Payables Outstanding
111.53
Days of Inventory on Hand
7.36
Receivables Turnover
4.51
Payables Turnover
3.27
Inventory Turnover
49.62
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0.42
Debt to Assets
0.18
Net Debt to EBITDA
0.01
Current Ratio
0.99
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
95818
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
34972
Debt to Market Cap
0.47

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Green Cures & Botanical Distribution Inc. Dividends
Year Dividends Growth

Green Cures & Botanical Distribution Inc. Profile

About Green Cures & Botanical Distribution Inc.

Green Cures & Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. It focuses on the production, distribution, and management of cannabis-derived products. The company's products comprise nutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty products. It also provides online community portals that supply public with information and resources regarding the benefits of cannabis-derived products. Green Cures & Botanical Distribution Inc. is based in Inglewood, California.

CEO
Mr. Rich Thomas
Employee
20
Address
11222 S La Cienega Boulevard
Inglewood, 90304

Green Cures & Botanical Distribution Inc. Executives & BODs

Green Cures & Botanical Distribution Inc. Executives & BODs
# Name Age
1 Mr. David Moceri
Chief Marketing Officer
70
2 Mr. Joseph Tragesser
Consultant & Advisor
70
3 Mr. Michael Lajtay
President, Chief Operating Officer and Lead Product Developer
70
4 Mr. Rich Thomas
Chief Executive Officer
70
5 Mr. Benjamin Craik
Chief Technology Officer
70

Green Cures & Botanical Distribution Inc. Competitors